{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:44:04Z","timestamp":1761101044532},"reference-count":42,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1842,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1111\/j.1399-3046.2010.01311.x","type":"journal-article","created":{"date-parts":[[2010,3,29]],"date-time":"2010-03-29T01:43:29Z","timestamp":1269827009000},"page":"683-687","source":"Crossref","is-referenced-by-count":4,"title":["Optimal approach to prevent veno-occlusive disease following hematopoietic stem cell transplantation in children"],"prefix":"10.1111","volume":"14","author":[{"given":"Zuzana","family":"Hassan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,8,16]]},"reference":[{"key":"10.1111\/j.1399-3046.2010.01311.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1055\/s-2002-23204","article-title":"Toxic injury to hepatic sinusoids: Sinusoidal obstruction syndrome (veno-occlusive disease)","volume":"22","author":"Deleve","year":"2002","journal-title":"Semin Liver Dis"},{"key":"10.1111\/j.1399-3046.2010.01311.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"255","DOI":"10.7326\/0003-4819-118-4-199302150-00003","article-title":"Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: A cohort study of 355 patients","volume":"118","author":"McDonald","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1399-3046.2010.01311.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/hep.1840040121","article-title":"Venocclusive disease of the liver after bone marrow transplantation: Diagnosis, incidence, and predisposing factors","volume":"4","author":"McDonald","year":"1984","journal-title":"Hepatology"},{"key":"10.1111\/j.1399-3046.2010.01311.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/00007890-198712000-00011","article-title":"Venoocclusive disease of the liver following bone marrow transplantation","volume":"44","author":"Jones","year":"1987","journal-title":"Transplantation"},{"key":"10.1111\/j.1399-3046.2010.01311.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1182\/blood.V85.11.3005.bloodjournal85113005","article-title":"The syndrome of hepatic veno-occlusive disease after marrow transplantation","volume":"85","author":"Bearman","year":"1995","journal-title":"Blood"},{"key":"10.1111\/j.1399-3046.2010.01311.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/sj.bmt.1705899","article-title":"Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: Update on defibrotide and other current investigational therapies","volume":"41","author":"Ho","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1111\/j.1399-3046.2010.01311.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1365-2036.2006.02742.x","article-title":"Review article: Updates in the pathogenesis and therapy of hepatic sinusoidal obstruction syndrome","volume":"23","author":"Helmy","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1399-3046.2010.01311.x-BIB8|cit8","first-page":"3599","article-title":"Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: A prospective cohort study of the European Group for Blood and Marrow Transplantation. European Group for Blood and Marrow Transplantation Chronic Leukemia Working Party","volume":"92","author":"Carreras","year":"1998","journal-title":"Blood"},{"key":"10.1111\/j.1399-3046.2010.01311.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1182\/blood-2003-01-0255","article-title":"Prior gemtuzumab ozogamicin exposure significantly increases the risk of veno-occlusive disease in patients who undergo myeloablative allogeneic stem cell transplantation","volume":"102","author":"Wadleigh","year":"2003","journal-title":"Blood"},{"key":"10.1111\/j.1399-3046.2010.01311.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"4568","DOI":"10.1182\/blood.V92.12.4568","article-title":"Norethisterone treatment, a major risk-factor for veno-occlusive disease in the liver after allogeneic bone marrow transplantation","volume":"92","author":"Hagglund","year":"1998","journal-title":"Blood"},{"key":"10.1111\/j.1399-3046.2010.01311.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"975","DOI":"10.7326\/0003-4819-128-12_Part_1-199806150-00002","article-title":"Ursodiol prophylaxis against hepatic complications of allogeneic bone marrow transplantation. A randomized, double-blind, placebo-controlled trial","volume":"128","author":"Essell","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1399-3046.2010.01311.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/(SICI)1096-8652(200005)64:1<32::AID-AJH6>3.0.CO;2-N","article-title":"The Japanese multicenter open randomized trial of ursodeoxycholic acid prophylaxis for hepatic veno-occlusive disease after stem cell transplantation","volume":"64","author":"Ohashi","year":"2000","journal-title":"Am J Hematol"},{"key":"10.1111\/j.1399-3046.2010.01311.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1182\/blood-2001-12-0159","article-title":"Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation","volume":"100","author":"Ruutu","year":"2002","journal-title":"Blood"},{"key":"10.1111\/j.1399-3046.2010.01311.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/sj.bmt.1703342","article-title":"A randomized trial of heparin plus ursodiol vs. heparin alone to prevent hepatic veno-occlusive disease after hematopoietic stem cell transplantation","volume":"29","author":"Park","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1111\/j.1399-3046.2010.01311.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.bbmt.2004.06.004","article-title":"A multiagent strategy to decrease regimen-related toxicity in children undergoing allogeneic hematopoietic stem cell transplantation","volume":"10","author":"Thornley","year":"2004","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1111\/j.1399-3046.2010.01311.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.bbmt.2006.09.012","article-title":"Systematic review of controlled clinical trials on the use of ursodeoxycholic acid for the prevention of hepatic veno-occlusive disease in hematopoietic stem cell transplantation","volume":"13","author":"Tay","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1111\/j.1399-3046.2010.01311.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1182\/blood.V79.11.2834.bloodjournal79112834","article-title":"Prevention of hepatic veno-occlusive disease after bone marrow transplantation by continuous infusion of low-dose heparin: A prospective, randomized trial","volume":"79","author":"Attal","year":"1992","journal-title":"Blood"},{"key":"10.1111\/j.1399-3046.2010.01311.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1600-0609.1991.tb01859.x","article-title":"Prophylactic heparin does not prevent liver veno-occlusive disease following autologous bone marrow transplantation","volume":"47","author":"Marsa-Vila","year":"1991","journal-title":"Eur J Haematol"},{"key":"10.1111\/j.1399-3046.2010.01311.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1097\/00007890-199604150-00014","article-title":"Low molecular weight heparin for the prevention of veno-occlusive disease of the liver in bone marrow transplantation patients","volume":"61","author":"Or","year":"1996","journal-title":"Transplantation"},{"key":"10.1111\/j.1399-3046.2010.01311.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1097\/00043426-200212000-00013","article-title":"Hepatic venoocclusive disease in blood and bone marrow transplantation in children and young adults: Incidence, risk factors, and outcome in a cohort of 241 patients","volume":"24","author":"Reiss","year":"2002","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1111\/j.1399-3046.2010.01311.x-BIB21|cit21","first-page":"185","article-title":"Phase II trial of heparin prophylaxis for veno-occlusive disease of the liver in children undergoing bone marrow transplantation","volume":"18","author":"Rosenthal","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1111\/j.1399-3046.2010.01311.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/sj.bmt.1702854","article-title":"Retrospective multivariate analysis of hepatic veno-occlusive disease after blood or marrow transplantation: Possible beneficial use of low molecular weight heparin","volume":"27","author":"Simon","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1111\/j.1399-3046.2010.01311.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/sj.bmt.1705297","article-title":"Use of prophylactic anticoagulation and the risk of hepatic veno-occlusive disease in patients undergoing hematopoietic stem cell transplantation: A systematic review and meta-analysis","volume":"37","author":"Imran","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1111\/j.1399-3046.2010.01311.x-BIB24|cit24","first-page":"1","article-title":"Role of PGE1 to prevent veno-occlusive disease of the liver after bone marrow transplantation","volume":"32","author":"Gluckman","year":"1990","journal-title":"Nouv Rev Fr Hematol"},{"key":"10.1111\/j.1399-3046.2010.01311.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/j.1365-2141.1993.tb03152.x","article-title":"A phase I\/II study of prostaglandin E1 for the prevention of hepatic venocclusive disease after bone marrow transplantation","volume":"84","author":"Bearman","year":"1993","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1399-3046.2010.01311.x-BIB26|cit26","article-title":"Hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation: Incidence, risk factors, and outcome","author":"Lee","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1111\/j.1399-3046.2010.01311.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"897","DOI":"10.3346\/jkms.2006.21.5.897","article-title":"Prophylactic low-dose heparin or prostaglandin E1 may prevent severe veno-occlusive disease of the liver after allogeneic hematopoietic stem cell transplantation in Korean children","volume":"21","author":"Song","year":"2006","journal-title":"J Korean Med Sci"},{"key":"10.1111\/j.1399-3046.2010.01311.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1517\/14712590903008507","article-title":"Insights into defibrotide: An updated review","volume":"9","author":"Morabito","year":"2009","journal-title":"Expert Opin Biol Ther"},{"key":"10.1111\/j.1399-3046.2010.01311.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/sj.bmt.1705485","article-title":"Stem cell transplantation in children with infantile osteopetrosis is associated with a high incidence of VOD, which could be prevented with defibrotide","volume":"38","author":"Corbacioglu","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1111\/j.1399-3046.2010.01311.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1182\/blood-2003-10-3612","article-title":"Prophylaxis with defibrotide prevents veno-occlusive disease in stem cell transplantation after gemtuzumab ozogamicin exposure","volume":"103","author":"Versluys","year":"2004","journal-title":"Blood"},{"key":"10.1111\/j.1399-3046.2010.01311.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.bbmt.2004.01.002","article-title":"Prevention of veno-occlusive disease with defibrotide after allogeneic stem cell transplantation","volume":"10","author":"Chalandon","year":"2004","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1111\/j.1399-3046.2010.01311.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/sj.bmt.1705696","article-title":"Prophylactic defibrotide in allogeneic stem cell transplantation: Minimal morbidity and zero mortality from veno-occlusive disease","volume":"40","author":"Dignan","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1111\/j.1399-3046.2010.01311.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1182\/blood.V82.3.732.732","article-title":"Prevention of regimen-related toxicities after bone marrow transplantation by pentoxifylline: A prospective, randomized trial","volume":"82","author":"Attal","year":"1993","journal-title":"Blood"},{"key":"10.1111\/j.1399-3046.2010.01311.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1182\/blood.V82.7.2025.2025","article-title":"A randomized controlled trial of pentoxifylline for the prevention of regimen-related toxicities in patients undergoing allogeneic marrow transplantation","volume":"82","author":"Clift","year":"1993","journal-title":"Blood"},{"key":"10.1111\/j.1399-3046.2010.01311.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/sj.bmt.1701321","article-title":"Parenteral glutamine protects hepatic function during bone marrow transplantation","volume":"22","author":"Brown","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1111\/j.1399-3046.2010.01311.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1182\/blood.V89.5.1501","article-title":"Treatment of hepatic venocclusive disease with recombinant human tissue plasminogen activator and heparin in 42 marrow transplant patients","volume":"89","author":"Bearman","year":"1997","journal-title":"Blood"},{"key":"10.1111\/j.1399-3046.2010.01311.x-BIB37|cit37","article-title":"Low incidence of hepatic veno-occlusive disease in pediatric patients undergoing hematopoietic stem cell transplantation attributed to a combination of intravenous heparin, oral glutamine, and ursodiol at a single transplant institution","author":"Lakshminarayanan","year":"2010","journal-title":"Pediatr Transplant"},{"key":"10.1111\/j.1399-3046.2010.01311.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/sj.bmt.1703881","article-title":"Recombinant tissue plasminogen activator for treatment of hepatic veno-occlusive disease following bone marrow transplantation in children: Effectiveness and a scoring system for initiating treatment","volume":"31","author":"Bajwa","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1111\/j.1399-3046.2010.01311.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/MBC.0b013e3282f2b5d9","article-title":"Early intervention with antithrombin III therapy to prevent progression of hepatic venoocclusive disease","volume":"19","author":"Peres","year":"2008","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/j.1399-3046.2010.01311.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/sj.bmt.1701172","article-title":"Glutamine and vitamin E in the treatment of hepatic veno-occlusive disease following high-dose chemotherapy","volume":"21","author":"Goringe","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1111\/j.1399-3046.2010.01311.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/sj.bmt.1702387","article-title":"N-acetylcysteine for hepatic veno-occlusive disease after allogeneic stem cell transplantation","volume":"25","author":"Ringden","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1111\/j.1399-3046.2010.01311.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/sj.bmt.1705896","article-title":"Successful treatment of hepatic veno-occlusive disease after myeloablative allogeneic hematopoietic stem cell transplantation by early administration of a short course of methylprednisolone","volume":"41","author":"Al Beihany","year":"2008","journal-title":"Bone Marrow Transplant"}],"container-title":["Pediatric Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-3046.2010.01311.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1399-3046.2010.01311.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T01:04:50Z","timestamp":1625619890000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-3046.2010.01311.x"}},"subtitle":["Editorial"],"short-title":[],"issued":{"date-parts":[[2010,8,16]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,9]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1399-3046.2010.01311.x","relation":{},"ISSN":["1397-3142"],"issn-type":[{"value":"1397-3142","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8,16]]}}}